Breaking News

AstraZeneca PLC (AZN)

Symbol	Exchange	Currency
AZN	London	GBP	Real-time
3LAZ	London	GBP	Real-time
3SAZ	London	GBP	Real-time
AZNl	BATS Europe	GBP	Delayed
AZNs	BATS Europe	SEK	Delayed
AZN	NASDAQ	USD	Real-time
AZNCF	OTC Markets	USD	Delayed
AZNN	Mexico	MXN	Delayed
AZN	Stockholm	SEK	Real-time
AZN	Frankfurt	EUR	Delayed
AZN	TradeGate	EUR	Delayed
AZN	Xetra	EUR	Delayed
AZNPy	Frankfurt	EUR	Delayed
AZN	Buenos Aires	ARS	Delayed

Add to/Remove from a Portfolio Add to Watchlist

10,250.0 +6.0 +0.06%

19/05 - Closed. Currency in GBP ( Disclaimer )

Volume: 1,682,202
Bid/Ask: 10,030.0 / 10,500.0
Day's Range: 10,088.0 - 10,276.0

Type: Equity

Market: United Kingdom

ISIN: GB0009895292

SEDOL: 0989529

News
Analysis & Opinion

AZN News

This page features the latest news about the AstraZeneca stock.

AstraZeneca In-Licenses New Suite Of COVID-19 Antibody Candidate(s)

By Benzinga - May 17, 2022

AstraZeneca plc (NASDAQ: AZN) moved to bolster its COVID-19 portfolio of antibodies with a $157 million licensing deal for experimental therapies developed by newly-launched UK-based biotech, RQ...

AstraZeneca wades deeper into COVID therapeutics

By FXEmpire - May 17, 2022

LONDON (Reuters) – AstraZeneca has signed a licence agreement with a small UK-based biotech company for a slate of COVID antibody therapies, the Anglo-Swedish pharmaceutical giant said on Tuesday.

AstraZeneca's Combination Inhaler Shines In Phase 3 Asthma Trial

By Benzinga - May 16, 2022

AstraZeneca Plc (NASDAQ: AZN) posted full results from the positive MANDALA Phase 3 trial of PT027, an albuterol/budesonide fixed-dose combination rescue medication in patients with asthma. The data...

AstraZeneca Joins Accumulus Synergy as a Sponsor to Accelerate the Delivery of Medicines to Patients

By Benzinga - May 12, 2022

BURLINGAME, Calif., May 12, 2022 (GLOBE NEWSWIRE) -- Accumulus Synergy, a nonprofit organization working to develop an information and data exchange platform aimed at transforming how drug...

U.K. shares higher at close of trade; Investing.com United Kingdom 100 up 1.45% By Investing.com - May 11, 2022

Investing.com – U.K. equities were higher at the close on Wednesday, as gains in the Industrial Metals & Mining, Oil & Gas Producers and Life Insurance/Assurance sectors propelled shares higher. At...

The Daily Biotech Pulse: Veru Shares Up On COVID Candidate Update, FDA Approves Lilly's COVID Treatment, Latest On Sanofi-AstraZeneca RSV Vaccine

By Benzinga - May 11, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Veru Suggested By FDA To Submit Emergency Use Request For Sabizabulin In COVID-19 In a Pre-EUA...

Sanofi-AstraZeneca Say New Nirsevimab Data Reinforce Efficacy Against RSV

By Benzinga - May 11, 2022

Sanofi SA (NASDAQ: SNY) and AstraZeneca plc (NASDAQ: AZN) have announced results from a prespecified pooled analysis of nirsevimab in respiratory syncytial virus (RSV). Results from the Phase 3 MELODY...

FDA Approval For AstraZeneca - Daiichi's Enhertu Expands To Earlier Use In Metastatic Breast Cancer

By Benzinga - May 05, 2022

The FDA has approved AstraZeneca plc (NASDAQ: AZN) and Daiichi Sankyo's (OTC: DSKYF) Enhertu (trastuzumab deruxtecan) for adult patients with unresectable or metastatic HER2-positive breast...

The Daily Biotech Pulse: AstraZeneca's 3 Product Updates, Jazz Pharma Licenses Sleeping Disorder Product, Argenx Aces Bleeding Disorder Study

By Benzinga - May 05, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus FDA Approval For AstraZeneca-Daiichi's Enhertu Expands To Earlier Use In Metastatic Breast...

FDA Accepts AstraZeneca's sBLA for Imfinzi (durvalumab) in biliary tract cancer (BTC) with Priority Review

By Benzinga - May 04, 2022

The U.S. Food and Drug Administration (FDA) has accepted AstraZeneca's (NASDAQ: AZN) supplemental Biologics License Application (sBLA) for Imfinzi (durvalumab), in combination with standard-of-care...

1 2 3 4 5 6 7 8 9 10

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:

Enrich the conversation
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically.
Use standard writing style. Include punctuation and upper and lower cases.
NOTE: Spam and/or promotional messages and links within a comment will be removed
Avoid profanity, slander or personal attacks directed at an author or another user.
Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I have read and understood Investing.com Canada's comment guidelines and agree to the terms described.

I Agree

AZN Comments

Write your thoughts about AstraZeneca PLC

Are you sure you want to delete this chart?

Delete Cancel

Post

Post also to:

Replace the attached chart with a new chart ?

Replace Cancel

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.

Dudley Stevens Oct 28, 2021 0:25

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

Double top in reach

0 0

Report

<div id="comment">
				<div class="comment js-comment" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="232079681">
    <div class="mainComment js-content">
       <div class="commentInnerWrapper">
        <a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody">
                					<span class="commentUsername">
                    	<a href="{userLink}" class="js-user-link js-user-name">{username}</a>
					</span>
                                <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
                <div class="commentDropDown js-commentDropDownWrapper " data-user-id="232079681" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

<div class="js-option addRow follow">
            <div class="js-follow-post-button">
                <span class="alertfollowIcon middle"></span>Follow this post            </div>
            <div class="js-unfollow-post-button displayNoneImp">
                <span class="alertUnfollowIcon middle"></span>Unfollow this post            </div>
        </div>

<div class="addRow js-option save">
		<a href="javascript:void(0);" class="js-save-item-btn" data-item-type="comments" data-item-id="{commentID}">
			<i class="saveItemBigIcon middle"></i>
			Save		</a>
	</div>
	<div class="addRow saveItemsConfirmation noHover displayNone js-saveItemResult">
		
<div class="content js-saveItemSuccess displayNone">
	<span class="mediumGreenSuccessIcon"></span><span>Saved. See <a href="/members-admin/saved-items" target="_blank">Saved Items</a>.</span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
<div class="content js-saveItemAlreadySaved saveItemAlreadySaved displayNoneImp">
	<span>This comment has already been saved in your <a href="/members-admin/saved-items" target="_blank">Saved Items</a></span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
	</div>

<div class="addRow js-option blockUser js-block-option" data-comment-id="{commentID}"  data-user-id="232079681">
			<a href="javascript:void(0);">
				<span class="blockIcon middle"></span>Block User			</a>
		</div>
				<div class="addRow shareButtons js-sharePopup displayNone">
			<div class="js-shareComment"><span class="js-shareCommentSpan"></span></div>
		</div>
	</div>
</div>
                 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div>             </div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="commentBigChart js-comment-chart" onclick="openViewChartPopup('{commentID}')">
					<img src="https://d68-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="232079681">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

<div class="reportComment js-flag float_lang_base_2">
                            <a href="javascript:void(0);" id="commentFlag_{commentID}">
                                <span class="reportCommentIcon middle"></span><span class="inlineblock middle">Report</span>
                            </a>
                        </div>
                    				</div>
					</div>
	   </div>
	</div>
	</div>			</div>
			<div id="reply">
				
    <div class="commentReply js-comment js-comment-reply" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="">
		<div class="commentInnerWrapper"><a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody js-content">
            				<span class="commentUsername">
					<a href="{userLink}" class="commentUsername js-user-link js-user-name" onMouseOver="">{username}</a>
				</span>
                        <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
			 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div> 			<div class="commentDropDown js-commentDropDownWrapper " data-user-id="" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

</div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="replyBigChart displayNone js-comment-chart">
					<img src="https://d68-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
				<span id="commentSmallChart{commentID}" class="commentSmallChart pointer js-comment-chart" onclick="openViewChartPopup('{commentID}')">
                    <img src="https://d68-invdn-com.investing.com/comments_images/{commentImageSmall}" width="116" height="52" alt="{commentAlt}">
                    <span class="chartMagnifyOverlay displayNone"></span>
                    <span class="searchGlassIcon chartMagnify displayNone"></span>
                </span>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

Are you sure you want to delete this chart?

Delete Cancel

Post

Replace the attached chart with a new chart ?

Replace Cancel

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

I feel that this comment is:

Spam

Offensive

Thank You!

Your report has been sent to our moderators for review

More Categories

1D1W1M6M1Y5YMax

S&P/TSX	20,181.92	+80.54	+0.40%
S&P/TSX 60	1,220.35	+2.40	+0.20%
US 30	31,443.1	+190.0	+0.61%
US 500	3,930.9	+30.1	+0.77%
S&P 500 VIX	29.35	0.00	0.00%
DAX	13,882.30	-125.46	-0.90%
Dollar Index	102.995	+0.244	+0.24%

Crude Oil WTI	109.02	-0.87	-0.79%
Brent Oil	111.45	-0.59	-0.53%
Natural Gas	8.082	-0.015	-0.19%
Gold	1,840.04	-1.16	-0.06%
Silver	21.864	-0.044	-0.20%
US Soybeans	1,692.62	+1.87	+0.11%
US Cotton #2	146.00	-1.32	-0.90%

USD/CAD	1.2817	-0.0008	-0.06%
EUR/USD	1.0570	-0.0016	-0.15%
USD/JPY	127.69	-0.10	-0.08%
GBP/USD	1.2451	-0.0008	-0.07%
CAD/USD	0.7802	+0.0007	+0.09%
EUR/CAD	1.3549	-0.0028	-0.21%
GBP/JPY	158.98	-0.25	-0.16%

Bombardier Inc	1.210	+0.020	+1.68%
Enbridge	44.44	+0.20	+0.45%
Air Canada	20.99	-0.05	-0.24%
Ovintiv	21.70	-0.39	-1.77%
Apple	137.35	-3.47	-2.46%
Alibaba ADR	87.69	+0.38	+0.44%
Twitter Inc	37.29	+0.44	+1.19%

Recent Quotes

	Name	Price	Chg.	Chg. %
	AZN	10,250.0	+6.0	+0.06%

Market Movers

Name	Last	Chg. %	Vol.
Barrick Gold	26.56	+4.36%	14.53M
Enbridge	56.94	-0.14%	9.39M
Canadian Natural	79.19	+0.52%	8.04M
Suncor Energy	48.57	-0.06%	7.94M
RBC	126.98	+0.80%	2.87M
Bank of Montreal	130.79	-1.28%	2.57M
Canadian National Railway	142.10	-2.12%	2.26M

Name	Last	Chg. %	Vol.
Anglo Pacific	2.76	+607.69%	0.25K
Rain City Resources	0.0500	+400.00%	145.01K
Telescope Innovations	0.69	+130.00%	1.50K
Beyond Medical Technologies	0.020	+100.00%	9.00K
Gravitas Financial Inc	0.010	+100.00%	10.00K
Columbia Care	0.12	+91.67%	10.00K
I3 Energy	0.445	+71.15%	388.90K

Name	Last	Chg. %	Vol.
Gnomestar Craft	0.005	-50.00%	129.75K
Centaurus Energy Inc	0.005	-50.00%	25.00K
Sensor Tech	0.005	-50.00%	40.00K
Volatus Capital	0.04	-43.75%	6.00K
Cariboo Rose Resources	0.0400	-38.46%	1.00K
Hilo Mining	0.22	-37.14%	16.12K
NSJ Gold	0.12	-36.11%	21.52K